Eficacia a 2 años de tocilizumab en pacientes con artritis reumatoide activa en la práctica clínica habitual-Reference-Cited by-同舟云学术

Eficacia a 2 años de tocilizumab en pacientes con artritis reumatoide activa en la práctica clínica habitual

Published:2017-03 Issue:2 Volume:13 Page:78-84
ISSN:1699-258X
Container-title:Reumatología Clínica
language:es
Short-container-title:Reumatología Clínica

Author:

Notario Ferreira Irene,Ferrer González Miguel Angel,Morales Garrido Pilar,González Utrilla Alfonso,García Sanchez Antonio,Soto Pino María José,Suero Rosario Evelyn,Caro Hernández Cristina,Añón Oñate Isabel,Pérez Albaladejo Lorena,Cáliz Cáliz Rafael

Publisher

Elsevier BV

Subject

Rheumatology

Reference29 articles.

1. Rheumatoid arthritis;Lee;Lancet,2001

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis.,2014

3. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis;Singh;Arthritis Rheumatol.,2016

4. Interleukin-6 as a therapeutic target in candidate inflammatory diseases;Nishimoto;Clin Pharmacol Ther.,2010

5. Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: Subanalysis of Spanish results of an open-label study close to clinical practice;Álvaro-Gracia;Reumatol Clin.,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study;Clinical Rheumatology;2022-05-10

2. Response to interleukin-6 receptor antagonists in patients with rheumatoid arthritis is independent of the number of prior used TNF inhibitors: A systematic review and metaanalysis;Joint Bone Spine;2021-01

3. Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data;Modern Rheumatology;2018-08-02

4. Tocilizumab treatment leads to improvement in disease activity regardless of CCP status in rheumatoid arthritis;Seminars in Arthritis and Rheumatism;2017-10